Hormonal and Intrauterine Contraception for Women Aged 40 Years and Older

Pazol K Zane SB Parker WY Hall LR Berg C Cook DA ; Centers for Disease Control and Prevention (CDC). Abortion surveillance – United States, 2008. MMWR Surveill. Summ. 60(15), 1–41 (2011).

Kang BM Wu TC . Effect of age on intrauterine insemination with frozen donor sperm. Obstet. Gynecol. 88(1), 93–98 (1996).

Cleary-Goldman J Malone FD Vidaver J Impact of maternal age on obstetric outcome. Obstet. Gynecol. 105(5 Pt 1), 983–990 (2005).

Mosher WD Jones J . Use of contraception in the United States: 1982–2008. Vital Health Stat. 23(29), 1–44 (2010).

Chakhtoura Z Canonico M Gompel A Scarabin PY Plu-Bureau G . Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis. J. Clin. Endocrinol. Metab. 96(4), 1169–1174 (2011).

Chakhtoura Z Canonico M Gompel A Thalabard JC Scarabin PY Plu-Bureau G . Progestogen-only contraceptives and the risk of stroke: a meta-analysis. Stroke 40(4), 1059–1062 (2009).

Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception 57(5), 315–324 (1998).

Heinemann LA Dinger JC . Range of published estimates of venous thromboembolism incidence in young women. Contraception 75(5), 328–336 (2007).

Dinger J Assmann A Möhner S Minh TD . Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case–control study. J. Fam. Plann. Reprod. Health Care 36(3), 123–129 (2010).

Kaunitz AM . Clinical practice. Hormonal contraception in women of older reproductive age. N. Engl. J. Med. 358(12), 1262–1270 (2008).

ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet. Gynecol. 115(1), 206–218.

Ozdegirmenci O Kayikcioglu F Akgul MA Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil. Steril. 95(2), 497–502 (2011).

Kucuk T Ertan K . Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers. Clin. Exp. Obstet. Gynecol. 35(1), 57–60 (2008).

Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 257(6), 796–800 (1987).

Curtis KM Marchbanks PA Peterson HB . Neoplasia with use of intrauterine devices. Contraception 75(Suppl. 6), S60–S69 (2007).

Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371(9609), 303–314 (2008).

Wilailak S Vipupinyo C Suraseranivong V Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study. BJOG 119(6), 672–677 (2012).

Green A Purdie D Bain C Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int. J. Cancer 71(6), 948–951 (1997).

Hillis SD Marchbanks PA Tylor LR Peterson HB . Poststerilization regret: findings from the United States collaborative review of sterilization. Obstet. Gynecol. 93(6), 889–895 (1999).

CDC. US medical eligibility criteria for contraceptive use 2010. www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm.